Quantum BioPharma Ltd.
QNTM
$3.02
-$0.34-9.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -84.30% | -178.49% | -261.70% | -111.98% | 20.66% |
| Total Depreciation and Amortization | 11.27% | 5.86% | -4.03% | -66.58% | -80.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 576.45% | 3,565.04% | 499.68% | 179.21% | -199.67% |
| Change in Net Operating Assets | -79.65% | 180.31% | 97.94% | 880.12% | 495.75% |
| Cash from Operations | -19.78% | -27.20% | -104.24% | -13.89% | 36.49% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -29.86% | 61.45% | -1,289.08% | -775.30% | -398.84% |
| Cash from Investing | -29.86% | 61.45% | -1,204.39% | -870.72% | -457.68% |
| Total Debt Issued | 429.40% | -- | 1,809.78% | 1,236.98% | -- |
| Total Debt Repaid | -2,429.83% | -1,390.54% | -701.46% | 51.64% | 66.31% |
| Issuance of Common Stock | -95.04% | -81.74% | 307.64% | 3,283.15% | 52,724.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -47.51% | -21.63% | 484.07% | 3,083.03% | 471.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -226.30% | -420.60% | 23.48% | 127.72% | 122.77% |